Citations

Institution: Mayo Clinic Clear

Showing 10 of 108083 citations.

Digital twin creation of a proton therapy treatment environment with hybrid LiDAR and RGB 3D camera
Dougherty, Jingjing M. , Tryggestad, E., Beltran, Chris , Tryggestad, Erik J, Beltran, Chris J , Dougherty, Jingjing M

Journal of Applied Clinical Medical Physics | August 16, 2025 | Volume: 26 | Issue: 8 | Pages: No page available

10.1002/acm2.70231 | PMID 40817419 Get It

AbstractIntroductionThis study evaluates the feasibility of utilizing a commercial‐grade 3D LiDAR/RGB camera, combined with 3D reconstruction software, to create an accurate and hyper‐realistic digital model of a proton therapy treatment room. This reconstructed model aims to enhance collision avoidance strategies and improve 3D machine model accessibility. Utilization of a 3D LiDAR/RGB camera as a radiotherapy environment modeling has not been reported prior.MethodsTo create a comprehensive 3D model of a half‐gantry proton therapy system, colored point cloud data was captured using the Matterport Pro 3 camera, a hybrid LiDAR and RGB imaging system with high‐resolution capabilities (134.2 MP), a 360° horizontal field of view, and 20 mm accuracy at 10 m. A total of 117 acquisition points, distributed across the treatment room with three camera heights, ensured complete coverage and minimal occlusions. Scanning, completed in under 3 hours, was monitored in real time using the Matterport App. Post‐scan processing involved denoising and converting the point cloud into 3D mesh structures using MeshLab, followed by refined pair‐wise iterative closest point (ICP) alignments. Textures and materials were assigned to reflect real‐world objects, and a ray‐tracing engine simulated realistic lighting in Blender. Animations illustrating the kinematics of the treatment couch and gantry were simulated in Blender for enhanced visualization.ResultsThe scanning process achieved complete data capture without missing information, attributed to strategic oversampling during data acquisition. The mean root mean square error (RMSE) of the ICP registration was 0.008 m. The validation process confirmed that the dimensions of the treatment couch within the digital model closely matched the actual measurements with less than 2 cm deviation, indicating high accuracy. The resulting digital twin provided a photorealistic and immersive representation of the proton therapy treatment room, serving as a valuable digital asset for various applications.ConclusionIt is possible to generate vendor‐independent and highly accurate 3D models of the proton treatment room environment with a commercial grade LiDAR/RGB camera to expand future research opportunities and education endeavors.
Establishing Clinically Distinct Patient Treatment Subgroups Following Anterior Cruciate Ligament Reconstruction: A Machine Learning Clustering Analysis
Lu, Yining , Kang, Louis , Mavrommatis, Sophia , Hevesi, Mario , Okoroha, Kelechi R. , Saris, Daniël B.F. , Krych, Aaron J. , Tagliero, Adam J. , Camp, Christopher L. , Tagliero, Adam , Lu, Yining , Krych, Aaron J , Hevesi, Mario , Kang, Louis S , Saris, Daniël B.F.

The American Journal of Sports Medicine | August 15, 2025 | Volume: 53 | Issue: 11 | Pages: 2542-2552

10.1177/03635465251360240 | PMID 40815848 Get It

Background: Treatment decisions in patients with anterior cruciate ligament (ACL) injuries are influenced by multiple factors, such as the desire to return to sports or symptomatic instability. Identifying the differential treatment effect of ACL reconstruction (ACLR) compared with nonoperative management on a patient-specific level can inform surgical decision-making. Hypothesis: Unsupervised machine learning can identify distinct patient subgroups based on outcome achievement after ACL injury, and ACLR will exert a protective effect on the development of posttraumatic osteoarthritis (PTOA) over nonoperative management. Study Design: Cohort study; Level of evidence, 3. Methods: A longitudinal populational registry identified patients with ACL injuries from 1990 to 2016 with a minimum 7.5-year follow-up. An unsupervised random forest algorithm was utilized to develop and validate patient subgroups. Treatment effects of ACLR on outcomes were analyzed using a machine learning causal inference estimator. Patient subgroup membership was incorporated into a multivariable logistic regression to identify factors predictive of optimal outcomes. Results: A total of 923 patients (785 primary ACLR, 138 nonoperative) were included. The random forest algorithm arrived at an optimal partition of 2 subgroups, with 653 patients in the optimal outcome subgroup (368 male [56.4%]; mean age, 26.0 ± 10.2 years; mean body mass index [BMI], 26.5 ± 4.30) and 270 patients in the suboptimal outcome subgroup (152 male [56.3%]; mean age, 35.0 ± 10.1 years; mean BMI, 30.5 ± 5.54). The latter group demonstrated significantly increased rates of secondary meniscal injury, development of symptomatic PTOA, and progression to total knee arthroplasty (TKA) at the final follow-up (all P < .01). In the optimal outcome subgroup, ACLR had significantly protective treatment effects on the risk of secondary meniscal injury (average treatment effect [ATE], 61%), contralateral ACL injury (ATE, 8%), symptomatic PTOA (ATE, 16%), and progression to TKA (ATE, 6%) (all P < .01). Conversely, in the suboptimal outcome subgroup, ACLR only protected against symptomatic PTOA (ATE, 11%) and progression to TKA (ATE, 8%) (both P < .01). Conclusion: Two clinically meaningful subgroups were identified from retrospectively collected data and found to experience differential treatment responses after ACL injuries. ACLR decreased the rate of development of PTOA and TKA in both subgroups but was not as effective in preventing secondary meniscal injuries or contralateral ACL injuries in patients who were older, heavier, or had concomitant medial meniscus injuries.
The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD
Akahoshi, Yu , Portelli, Joseph , Katsivelos, Nikolaos , Louloudis, Ioannis, Aguayo‐Hiraldo, Paibel , Ayuk, Francis , Chanswangphuwana, Chantiya , Choe, Hannah , Eder, Matthias , Etra, Aaron , Hexner, Elizabeth O. , Olson, Timothy S. , Schechter, Tal, Marx, Julia, Vášová, Ingrid, Weber, Daniela , Wölfl, Matthias , Baez, Janna , Eng, Gilbert, Gleich, Sigrun, Kowalyk, Steven, Morales, George , Spyrou, Nikolaos , Young, Rachel , DeFilipp, Zachariah , Nakamura, Ryotaro , Ferrara, James L.M. , Louloudis, Ioannis E , Merli, Pietro , Olson, Timothy S , Qayed, Muna , Reshef, Ran , Ullrich, Evelyn , DeFilipp, Zachariah , Hogan, William J , Nakamura, Ryotaro , Levine, John E , Hexner, Elizabeth , Aguayo-Hiraldo, Paibel , Katsivelos, Nikolaos , Akahoshi, Yu , Kitko, Carrie L. , Kraus, Sabrina , Pašić, Ivan , Reshef, Ran , Schechter, Tal, Zeiser, Robert , Hogan, William J. , Levine, John E.

Blood Advances | August 15, 2025 | Volume: 9 | Issue: 22 | Pages: 5763-5773

10.1182/bloodadvances.2025017116 | PMID 40815797 Get It

Abstract Changes in the clinical symptoms of acute graft-versus-host disease (GVHD) are currently used to assess treatment responses. The Mount Sinai Acute GVHD International Consortium (MAGIC) consortium has recently revealed that the integration of serum biomarkers with clinical symptoms at the onset of treatment in a MAGIC composite score (MCS) more accurately predicts treatment response and 6-month nonrelapse mortality (NRM) than clinical symptoms alone. In this study, we evaluated whether the integration of serum biomarkers and clinical symptoms on day 28 (D28) would also better predict NRM than clinical response only (CRO). We analyzed data from 1135 patients receiving systemic treatment for acute GVHD and created a fourth MCS category for patients with complete resolution of symptoms and low-risk clinical biomarkers on D28. Using a classification and regression tree model with 6-month NRM as the end point, we identified status of MCS 0 or MCS 1 at D28 as responses, which we termed the MAGIC composite response (MCR). In the validation cohort (n = 309), MCR more accurately predicted 6-month NRM than CRO (area under the curve: 0.77 vs 0.69; P = .014) and demonstrated higher negative and positive predictive values. MCR correctly reclassified both clinical nonresponders and responders: 28 of 213 clinical responders (13%) became nonresponders with fivefold higher NRM (34.3% vs 6.8%, P &lt; .001) and a larger group (29/96, 30%) of clinical nonresponders became responders with sixfold lower NRM (7.6% vs 50.7%, P &lt; .001). These findings support the use of MCR as a superior surrogate end point for long-term GVHD control and survival in future clinical trials.
Affordable Care Act Expansion and Orthopaedic Surgery
Hiredesai, Annika N. , Holle, Alejandro M. , Payne, Cynthia S. , Haglin, Jack M. , Patel, Karan A. , Payne, Camryn S , Haglin, Jack M , Patel, Karan , Holle, Alejandro

JBJS Reviews | August 15, 2025 | Volume: 13 | Issue: 8 | Pages: No page available

10.2106/jbjs.rvw.25.00113 | PMID 40892536 Get It

» Affordable Care Act Medicaid expansion increased orthopaedic surgery access and utilization among Medicaid patients, including for racial and ethnic minorities. » Despite improved coverage, Medicaid patients continue to face significant real-world barriers to orthopaedic care, including lower appointment success and longer wait times compared with privately insured patients. » Evidence on cost and quality impacts remains limited, with early signals of increased reimbursements, higher charges, and some quality improvements postexpansion.
Novel liquid immunocytochemistry with machine learning analysis for bladder cancer detection
Patel, Ankush , Song, Yi , Chu, Wenjiang, Patel, Ankush U , Atiya, Samir , Parwani, Anil Vasdev

Journal of Histotechnology | August 15, 2025 | Volume: 49 | Issue: 1 | Pages: 4-12

10.1080/01478885.2025.2546655 | PMID 40815554 Get It

Anxiety and Depression in Adults With Vestibular Disorders: A Systematic Review and Meta‐Analysis
Kim, C.H. , McCray, Lauren R. , Nguyen, Shaun A. , Jafri, Shabih , Rizk, Habib G. , Kim, Cory Hyun-Su , Rizk, Habib , Staab, Jeffrey P.

The Laryngoscope | August 15, 2025 | Volume: 136 | Issue: 2 | Pages: 535-546

10.1002/lary.70055 | PMID 40815545 Get It

ABSTRACT Objective To derive precise estimates of anxiety and depressive disorder prevalence in patients with common vestibular disorders. Data Sources CINAHL, Cochrane Library, PubMed, PsycINFO, and SCOPUS. Review Methods This systematic review and meta‐analysis was reported per PRISMA guidelines. Outcomes included continuous measures (mean), proportions (%), and relative risks (RR) with 95% confidence intervals. Results Eighty‐five studies ( n = 764,403) examining anxiety, depression, and vestibular disorders in adults were included. Mean ages were 50.3 (vestibular) and 46.7 (control); females comprised 63.8% and 64.3%, respectively. Patients with vestibular disorders had significantly higher rates and risks of anxiety (31.4% vs. 8.3%, p < 0.0001; RR = 1.50, 95% CI: 1.1–2.0) and depression (28.3% vs. 4.7%, p < 0.0001; RR = 2.9, 95% CI: 1.8–4.4) than controls. Elevated rates were observed in benign paroxysmal positional vertigo (30.6%, 23.6%), Meniere's disease (47.0%, 43.1%), vestibular migraine (46.5%, 35.7%), and vestibular neuritis (19.4%, 20.7%) (all p < 0.0001). Episodic disorders showed higher prevalence than vestibular neuritis. Patients with unspecified peripheral vestibular disorders also had significantly higher anxiety (12.1%) and depression (13.2%) rates than controls. Meta‐regression revealed significant associations between Dizziness Handicap Inventory (DHI) scores and Hospital Anxiety and Depression Scale (HADS) anxiety and depression subscales. Conclusions This meta‐analysis offers the most precise prevalence and relative risk estimates of anxiety and depressive disorders in vestibular illness. The greater risk in episodic versus single‐event vestibular disorders may inform the understanding of vestibular–psychiatric comorbidity mechanisms.
Ebstein anomaly update: the evolution of care and the revolution of surgical strategy
Jamal, Tamer, Stephens, Elizabeth H. , Swan, Elena Ashikhmina , Weatherhead, Jeffrey R, Dearani, Joseph A., Taggart, Nathan, Qureshi, M. Yasir , Swan, Elena A, Taggart, Nathaniel W. , Weatherhead, Jeffrey , Dearani, Joseph A.

Expert Review of Cardiovascular Therapy | August 15, 2025 | Volume: 23 | Issue: 9 | Pages: 493-505

10.1080/14779072.2025.2544817 | PMID 40815234 Get It

Surgical Disconnection of a Galenic Dural Arteriovenous Fistula Through a Supracerebellar Infratentorial Approach: 2-Dimensional Operative Video
Alexander, A. Yohan , Cohen-Cohen, Salomón , Torregrossa, Fábio , Alexander, A Yohan , Lanzino, Giuseppe

Operative Neurosurgery | August 15, 2025 | Volume: 29 | Issue: 3 | Pages: 443-444

10.1227/ons.0000000000001439 | PMID 40815172 Get It

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for the Role of Radiosurgery for Patients With Functioning Pituitary Adenomas
Green, Sheryl , Lehrer, Eric J. , Sheehan, Jason , Cifarelli, Christopher P. , Recinos, Pablo F. , Ziu, Mateo , Ormond, David Ryan , Germano, Isabelle M.

Neurosurgery | August 15, 2025 | Volume: 97 | Issue: 3S | Pages: S36-S43

10.1227/neu.0000000000003582 | PMID 40815129 Get It

BACKGROUND: Patients with functioning pituitary adenomas (FPA) require a multidisciplinary team-based approach to select best medical, surgical, and radiation treatments, including stereotactic radiosurgery (SRS). OBJECTIVE: The aim of this study was to provide evidence-based recommendations on the use of SRS for adult patients with FPA. METHODS: PubMed and Embase were searched from data base inception to June 8, 2021. Full-text articles were then screened using published exclusion/inclusion criteria. Evidence tables were developing based on data extraction from the full-text reviews, and evidence-based recommendations were finalized. RESULTS: Of the total 1842 abstracts pertinent to this topic, 343 full articles met eligibility. Of these, 21 met entry criteria and were included in the evidence tables. The provided Class III evidence supported 2 Level III recommendations: 1. SRS, hypofractionated SRS, fractionated (>5 fractions) radiotherapy, and conventional radiation therapy provide excellent radiographic control with variable hormonal reduction and endocrine remission rates. For SRS and fractionated radiotherapy hormonal reduction may continue for up to 10 years after treatment. 2. Clinicians may continue to administer endocrine suppressive medical treatment before SRS as this may not affect radiographic control. CONCLUSION: This systematic review provides evidence-based recommendations to guide providers caring for adult patients with FPA when making decisions pertinent to radiosurgery. The CNS Guidelines Committee will continue to pursue timely updates to further improve the care of patients with this diagnosis.
Evaluation of [18F]F-CNBI and [18F]F-CNPI PET Probes in GSK-3β Transgenic Mice
Kethamreddy, Manasa, Gundam, Surendra Reddy, Rivera, Alexander, Bansal, Aditya , Lim, Do Young , Giri, Sharmila, Larson, Nicholas B. , Lowe, Val J. , Pandey, Mukesh K. , Rivera, Andy González, Pandey, Mukesh K , Larson, Nicholas B , Wootla, Bharath , Baker, Darren J.

ACS Chemical Neuroscience | August 15, 2025 | Volume: 16 | Issue: 17 | Pages: 3340-3353

10.1021/acschemneuro.5c00442 | PMID 40815164 Get It